Minimal Traumatic Brain Injury in Mice: Protease-Activated Receptor 1 and Thrombin-Related Changes

J Neurotrauma. 2016 Oct 15;33(20):1848-1854. doi: 10.1089/neu.2015.4146. Epub 2016 Feb 17.

Abstract

Minimal traumatic brain injury (mTBI) is partially defined by the existence of retrograde amnesia and is associated with microscopic bleeds containing activated coagulation factors. In a previous study, we have found that mTBI immediately releases thrombin-like activity in the brain, which induces amnesia by activating protease-activated receptor 1 (PAR-1) and blocking long-term potentiation (LTP). In the present study, we assessed the effects of mTBI on thrombin and PAR-1 levels in the brain using the same model. After the immediate elevation, thrombin activity returned to baseline 1 h post-trauma and increased again 72 h later (42% relative to control; p < 0.005). These changes were associated with a significant increase in PAR-1 levels 24 (17%; p < 0.05) and 72 h (20%; p < 0.05) post-trauma. Interestingly, the late elevation in thrombin-like activity was also associated with elevation of the major central nervous system thrombin inhibitor, protease nexin-1, 72 h post-mTBI (10%; p < 0.005). When thrombin was injected into brain ventricles, an increased sensitivity to seizure-like activity was detected at 72 h post-mTBI. The results are compatible with astrocyte activation post-mTBI resulting in increased thrombin secretion, PAR-1 expression, and seizure sensitivity.

Keywords: PAR-1; astrocytes; mTBI; thrombin.

MeSH terms

  • Animals
  • Astrocytes / metabolism
  • Brain Concussion / complications
  • Brain Concussion / metabolism*
  • Brain Concussion / physiopathology*
  • Male
  • Mice
  • Mice, Inbred ICR
  • Receptor, PAR-1 / metabolism*
  • Seizures / etiology
  • Thrombin / metabolism*

Substances

  • Receptor, PAR-1
  • Thrombin